Pharmaids Pharmaceuticals Limited (PHARMAID) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE117D01018
Key metrics
- Market Cap
- ₹113 Cr
- P/E Ratio
- —
- EPS
- -1.27
- Book Value
- 13.5
- P/B Ratio
- 2.37
- ROE
- -24.61%
- ROCE
- -21.93%
- Debt / Equity
- 0.49
- Net Margin
- -42.02%
- Revenue Growth
- 43.37%
- Profit Growth
- -8.73%
- Dividend Yield
- —
- 52W High
- ₹66.00
- 52W Low
- ₹25.60
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. It provides pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile, pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine, 2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino thiophene-3-carbonitrile, 4-amino-2-methyl-10h-thiene benzodiazepine hydrochloride, 2,4-diamino-6-chloropyrimidine, hydronopol, squalene, 5-chloro-3-phenylanthranil, 2-amino-2,5-dichlorobenzophenone, 6-fluoro-3-4-piperidinyl-1,2-benzisoxazole hcl, 3-2-methyl-4H-pyrido pyrimidin-4-one, 4-n-hexyl resorcinol, triazole kopoxil, CAB-60, CABER-4, CAB-70, DTV, avobenzone, nopol, hydronopol, and narwedine. The company also offers active pharmaceuticals ingredients, including voglibose, silodosin, vitamin K2-7, UDCA, P5P, fluralaner, afoxolaner, maropitant, grapiprant, firocoxib, carprofen, loratadine, desloratadine, lamotrigine, gliclazide, and minoxidil. Pharmaids Pharmaceuticals Limited was incorporated in 1989 and is based in Bengaluru, India.
- Headquarters
- Bengaluru, India
- Employees
- 127
- Promoter Holding
- 74.26%
The full Pharmaids Pharmaceuticals Limited analysis
Create a free account to open the complete PHARMAID deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.